We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
–
AUM
$787M
AUM Growth
+$80.8M
Cap. Flow
+$26.5M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.98%
Holding
498
New
39
Increased
268
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.78M
3
ETN icon
Eaton
ETN
+$1.18M
4
DHR icon
Danaher
DHR
+$1.12M
5
HBAN icon
Huntington Bancshares
HBAN
+$1.09M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.97M
2
VOOG icon
Vanguard S&P 500 Growth ETF
VOOG
+$1.15M
3
VOOV icon
Vanguard S&P 500 Value ETF
VOOV
+$897K
4
XEC
CIMAREX ENERGY CO
XEC
+$886K
5
ALXN
Alexion Pharmaceuticals
ALXN
+$822K

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 12.65%
3 Healthcare 10.27%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAL icon
251
Halliburton
HAL
$26.4B
$603K 0.08%
24,620
+1,940
+9% +$40.9K
ATVI
252
DELISTED
Activision Blizzard
ATVI
$601K 0.08%
10,112
+793
+9% +$43.9K
CCL icon
253
Carnival Corporation Ltd
CCL
$38B
$600K 0.08%
11,808
-1,727
-13% -$77.1K
AMD icon
254
Advanced Micro Devices
AMD
$791B
$598K 0.08%
13,039
+596
+5% +$21.9K
CNC icon
255
Centene
CNC
$30.1B
$591K 0.08%
9,390
+610
+7% +$33.1K
DVY icon
256
iShares Select Dividend ETF
DVY
$23.6B
$583K 0.07%
5,521
-625
-10% -$64.4K
VRTX icon
257
Vertex Pharmaceuticals
VRTX
$122B
$583K 0.07%
2,663
+63
+2% +$12.8K
HUM icon
258
Humana
HUM
$44B
$579K 0.07%
1,580
+55
+4% +$17.4K
EXC icon
259
Exelon
EXC
$46.6B
$574K 0.07%
17,637
-854
-5% -$27.6K
IWP icon
260
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$569K 0.07%
7,460
– –
SBAC icon
261
SBA Communications
SBAC
$19.3B
$569K 0.07%
2,357
+16
+0.7% +$3.79K
ELV icon
262
Elevance Health
ELV
$81.6B
$568K 0.07%
1,880
+510
+37% +$140K
RACE icon
263
Ferrari
RACE
$69.9B
$558K 0.07%
3,375
+218
+7% +$35.3K
WBA
264
DELISTED
Walgreens Boots Alliance
WBA
$557K 0.07%
9,436
-4,147
-31% -$239K
WDC icon
265
Western Digital
WDC
$184B
$556K 0.07%
11,600
-1,293
-10% -$53.9K
ECL icon
266
Ecolab
ECL
$78.6B
$555K 0.07%
2,877
+311
+12% +$59K
ALC icon
267
Alcon
ALC
$33.9B
$552K 0.07%
9,746
-961
-9% -$55K
IWF icon
268
iShares Russell 1000 Growth ETF
IWF
$120B
$551K 0.07%
12,532
– –
EW icon
269
Edwards Lifesciences
EW
$50B
$549K 0.07%
7,050
+327
+5% +$25.5K
BP icon
270
BP
BP
$114B
$539K 0.07%
14,278
+319
+2% +$12.1K
DRI icon
271
Darden Restaurants
DRI
$23.7B
$528K 0.07%
4,845
+457
+10% +$51.9K
EFA icon
272
iShares MSCI EAFE ETF
EFA
$78.5B
$528K 0.07%
7,605
-140
-2% -$9.46K
SPGI icon
273
S&P Global
SPGI
$122B
$525K 0.07%
1,924
+26
+1% +$6.75K
SO icon
274
Southern Company
SO
$106B
$524K 0.07%
8,224
+365
+5% +$22.6K
TSLA icon
275
Tesla
TSLA
$1.22T
$514K 0.07%
18,435
+2,385
+15% +$51.7K
9 10
11
12 13

Similar funds

SIM
Sadoff Investment Management Milwaukee, Wisconsin $1.28B AUM 6.95% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
ACP
Ashfield Capital Partners San Francisco, California $1.19B AUM 14.56% 1-Year Est. Return
DWM
Doyle Wealth Management St. Petersburg, Florida $1.16B AUM 9.32% 1-Year Est. Return
H6H
Hightower 6M Holding Wichita, Kansas $1.11B AUM

Corient Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.

  • Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
  • Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
  • Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
  • Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
  • Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
  • Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.